Selective Serotonin Reuptake Inhibitors for Cessation of Betel Quid Use in Patients with Major Depressive Disorder in Taiwan

Selective Serotonin Reuptake Inhibitors for Cessation of Betel Quid Use in Patients with Major Depressive Disorder in Taiwan

<b>Background/Objectives</b>: Major depressive disorder (MDD) frequently co-occurs with substance use disorders such as alcohol and nicotine use disorders. Comorbid substance use disorders worsen the clinical symptoms of MDD and exacerbate addictive behaviors and presentations. However,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chung-Chieh Hung, Hung-Pin Tu, Chia-Min Chung
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Biomedicines
Subjects:	abstinence therapy antidepressant betel quid use disorder major depressive disorder
Online Access:	https://www.mdpi.com/2227-9059/12/11/2633
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Maternal betel quid use during pregnancy and child growth: a cohort study from rural Bangladesh
by: Mohammad Redwanul Islam, et al.
Published: (2024-12-01)

Quantification of betel quid hygroscopicity in context to saliva: A proof of concept for future studies
by: Sachin C. Sarode, et al.
Published: (2023-01-01)

Epidemiology of quid usage and its possible association with the occurrence of oral mucosal lesions
by: Sultan A. Almalki, et al.
Published: (2024-11-01)

Effectiveness of areca nut and products containing areca nut cessation interventions: A network meta-analysis
by: Anusa Arunachalam Mohandoss, et al.
Published: (2024-07-01)

Preclinical methodologies for studying smokeless tobacco-induced oral carcinogens: A perspective
by: Gargi S. Sarode, et al.
Published: (2023-09-01)

Estimation of myeloperoxidase levels in smokers, pan chewers, and normal individuals using enzyme-linked immunosorbent assay: An observational study
by: Meyyappan Arunachalam, et al.
Published: (2024-01-01)

Neuroinflammation and major depressive disorder: astrocytes at the crossroads
by: Melissa Puentes-Orozco, et al.
Published: (2024-11-01)

Association of inflammation cytokines with cognitive function in first-episode major depressive disorder
by: Yan Qing Xi, et al.
Published: (2025-01-01)

Major Depressive Disorder as a Condition Negatively Impacting Both Mental and Physical Functioning. What to Do When There Is Treatment Resistance?
by: Monika Makar, et al.
Published: (2025-01-01)

The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
by: Caroline Barkholt Kamp, et al.
Published: (2025-01-01)

Clinical Patterns of Metabolic Syndrome in First-Hospitalized Major Depressive Disorder Patients: Comparison of Antidepressant-Exposed and Drug-Naïve Groups
by: Wang S, et al.
Published: (2024-11-01)

The association between gestational selective serotonin reuptake inhibitor (SSRI) treatment and newborn thyroid screen: a large-scale cohort study
by: Orian Raviv, et al.
Published: (2025-01-01)

Effect of the Extraction Solvent Polarity and the Ratio of Feed and Solvent on the Phytochemical Content and Antioxidant Activity of Red Betel Leaves (Piper crocatum)
by: Monika Rahardjo, et al.
Published: (2018-03-01)

BETEL LEAF OIL AS A NATURAL DISINFECTION AGENT IN RADIOLOGICAL EQUIPMENT (STUDY OF MICROBIAL QUANTITY OF RADIOGRAPHIC CASSETTE)
by: Saifudin, et al.
Published: (2023-03-01)

A systematic review of the reasons for quitting and/or reducing alcohol among those who have received alcohol use disorder treatment
by: Christiana Prestigiacomo, et al.
Published: (2024-12-01)

The Effectiveness of Ethanol Extract of Red Betel Leaf (Piper crocatum) Againts Mortality of Boophilus microplus Larvae in Vitro
by: Meta Aprilia, et al.
Published: (2019-12-01)

Uji Aktivitas Antifungi Ekstrak Daun Sirih (Piper betle L) terhadap Saprolegnia sp. Secara In Vitro <br><i>[Antifungal Activities Test Of Betel Leaf Extract (Piper betle L) On Saprolegnia sp. By In Vitro]<i>
by: Rahayu Kusdarwati, et al.
Published: (2013-04-01)

Valorization of betel leaves byproducts: A novel ingredient for sustainable cookie development
by: Sangeetha Karunanithi, et al.
Published: (2024-12-01)

The Relationship between Chewing Betel Habit and Periodontal Disease in an Indonesian Village Community - An Evaluative Study
by: Nurdin Nurdin, et al.
Published: (2024-11-01)

The Use Of Mirtazapine As A Hypnotic
by: Francisca Magalhães Scoralick, et al.
Published: (2024-11-01)

A Comparison of Sexual Dysfunctions in Female Patients with Major Depressive Disorder and Panic Disorder
by: Tonguç Demir Berkol, et al.
Published: (2014-08-01)

Medium Time Heating of Syrop from Red Betel Leaf (Piper crocatum ruiz pav) Can Reduce Carcinoembryonic Antigen (CEA) Level Among Adult Women in Southeast Sulawesi, Indonesia
by: Hariani Hariani, et al.
Published: (2025-01-01)

Obsessive-compulsive disorder, major depressive disorder, and addiction: the vicious relationship
by: Rifaat S. El-Mallakh, et al.
Published: (2024-11-01)

Plants with Potential Importance in Supporting the Treatment of Depression: Current Trends, and Research
by: Renata Nurzyńska-Wierdak
Published: (2024-11-01)

Surge in antidepressant usage among adolescents and young adults during the COVID-19 pandemic: insights from an interrupted time series analysis
by: Zeno Di Valerio, et al.
Published: (2024-01-01)

Quality evaluation of Idli prepared from betel leaves essential oil nanoemulsion treated stored batter
by: Sangeetha Karunanithi, et al.
Published: (2024-12-01)

Uji Efektifitas Ekstrak Daun Sirih Merah (Piper rocatum) Terhadap Bakteri Aeromonas hydrophila Secara In Vitro <br><i>[ Effectines Of Leaves Extracts Red Betel (Piper crocatum) Againts Of Bacteria Aeromonas hydrophila In Vitro ]<i>
by: Ratih Kusuma Wardani, Wahyu Tjahjaningsih, Boedi Setya Rahardja
Published: (2012-04-01)

Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrumResearch in context
by: Thuy-Dung Nguyen, et al.
Published: (2025-02-01)

Targeting serotonin receptors with phytochemicals – an in-silico study
by: Amir Elalouf, et al.
Published: (2024-12-01)

Abstinence Self-Efficacy and Resilience in Persons with Substance Use Disorder
by: L. Iris Devi, et al.
Published: (2023-10-01)

Causal relationship between major depressive disorder, anxiety disorder and constipation: a two-sample Mendelian randomization study
by: ZhiYu Deng, et al.
Published: (2024-11-01)

Early growth response 1 (EGR1) is downregulated in peripheral blood from patients with major psychiatric disorders
by: Giovana Bristot, et al.
Published: (2024-12-01)

Sex-Based Variations in Hemato-Physiological Characteristics of Patients with Major Depressive Disorder: Clinical and Socioeconomic Insights
by: Basim A. Abd, et al.
Published: (2024-12-01)

The neural correlates of guilt highlight preclinical manifestations between bipolar and major depressive disorders
by: Yu-Chi Lo, et al.
Published: (2025-02-01)

Association between prescriber practices and major depression treatment outcomes
by: Sarah Rathnam, et al.
Published: (2024-12-01)

Role of self-efficacy in dealing with patients with alcohol dependence syndrome
by: Treiadalang Nongtdu, et al.
Published: (2024-12-01)

Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization
by: B. M. Holdovskyy, et al.
Published: (2019-04-01)

The Influence of Monoamine Oxidase Variants on the Risk of Betel Quid-Associated Oral and Pharyngeal Cancer
by: Ping-Ho Chen, et al.
Published: (2014-01-01)

Cytochrome P450 Metabolism of Betel Quid-Derived Compounds: Implications for the Development of Prevention Strategies for Oral and Pharyngeal Cancers
by: Che-Yi Lin, et al.
Published: (2013-01-01)

Evaluating the Efficacy of Psychiatric Interventions on Occupational Dysfunction in Major Depressive and Anxiety Disorder Patients
by: Kalliopi Iliou, et al.
Published: (2024-10-01)